Industrials

Mise à disposition du Document d’Enregistrement Universel 2024

Collaboration between AMIAD and Dassault Aviation

The electronic-grade sulfuric acid market is projected to grow at a 6.60% CAGR from 2025-2030 due to increased semiconductor demand. With 96% purity, it cleans and etches wafer chips, vital for semiconductor industry growth. Major regions include Asia-Pacific and the Americas, with key players like BASF and Thermo Fisher Scientific. The report offers valuable insights for businesses on market trends, competitive landscapes, and growth opportunities across various sectors like automotive and healthcare.

Kenya's construction industry is set for a 2.9% growth in 2025, driven by investments in transport, renewable energy, and housing. The FY2025-26 Budget supports this growth, with significant allocations to key sectors. The industry is projected to grow at an annual rate of 5.5% between 2026-2029.

The global patient handling equipment market is set to grow from USD 12.4 billion in 2025 to USD 16.4 billion by 2030, at a CAGR of 5.8%. Key growth drivers include the aging population and rising prevalence of cardiovascular diseases, necessitating advanced and ergonomic devices. A surge in home healthcare services across North America, Europe, and Asia Pacific further boosts demand. The patient transfer devices segment, particularly patient lifts, dominates due to increasing awareness and musculoskeletal injuries among healthcare staff. The Asia Pacific region, driven by countries like China and India, is predicted to grow significantly. Leading companies include Arjo, Stryker, and Baxter International.

Burlingame, CA, June 18, 2025 (GLOBE NEWSWIRE) -- The Coherent Market Insights reveals that the Critical Limb Ischemia Treatment Market is estimated to be valued at USD 5.55 Bn in 2025 and is expected to reach USD 10.02 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032. The critical limb ischemia treatment market is projected to experience significant growth during the forecast period. Key factors driving this expansion include the increasing global geriatric population and the rising prevalence of peripheral artery disease, both of which are contributing to a growing demand for effective treatment options.

Explore the Phenylketonuria Therapeutics market with our comprehensive report, detailing current and future competition. Discover key trends, pipeline developments, and market dynamics shaping the PKU landscape through data-driven insights and expert analysis. Stay ahead in this evolving therapeutic domain.